Mohamed Benderdour
- Rheumatology top 1%
- Osteoarthritis Treatment and Mechanisms 31
- Biomaterials top 2%
- Electrospun Nanofibers in Biomedical Applications 6
- Pharmaceutical Science top 2%
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects 35
- Cancer Research top 5%
-
- RNA Interference and Gene Delivery 16
- Peroxisome Proliferator-Activated Receptors 12
- Advanced biosensing and bioanalysis techniques 12
- Bone Metabolism and Diseases 6
-
- Virus-based gene therapy research 6
- Co-authors
- Julio FernandesPatrick LavigneHassan FahmiQin ShiÉric BeaumontJohanne Martel‐PelletierJean‐Pierre PelletierKarin A. Corsi
- Journals
- Journal of Biological Chemistry (1 paper)SHILAP Revista de lepidopterología (1 paper)Biomaterials (1 paper)
In The Last Decade
Mohamed Benderdour
84 papers receiving 3.8k citations
Peers
Comparison fields: 5 of 135
- Rheumatology 978
- Biomaterials 459
- Pharmaceutical Science 203
- Pharmacology 544
- Cancer Research 391
Countries citing papers authored by Mohamed Benderdour
This map shows the geographic impact of Mohamed Benderdour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamed Benderdour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamed Benderdour more than expected).
Fields of papers citing papers by Mohamed Benderdour
This network shows the impact of papers produced by Mohamed Benderdour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamed Benderdour. The network helps show where Mohamed Benderdour may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mohamed Benderdour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 32 | |
| 4 | 2021 | 19 | |
| 5 | Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications | 2020 | 1 |
| 6 | 2020 | 10 | |
| 7 | 2020 | 26 | |
| 8 | 2018 | 62 | |
| 9 | 2017 | 29 | |
| 10 | 2014 | 1 | |
| 11 | 2010 | 71 | |
| 12 | 2010 | 88 | |
| 13 | 2008 | 138 | |
| 14 | 2006 | 12 | |
| 15 | 2005 | 317 | |
| 16 | 2005 | 41 | |
| 17 | 2005 | 78 | |
| 18 | 2002 | 79 | |
| 19 | 2001 | 40 | |
| 20 | 1997 | 38 |
About Mohamed Benderdour
Mohamed Benderdour is a scholar working on Rheumatology, Pharmacology and Immunology and Allergy, having authored 87 papers that have together received 3.9k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (35 papers), Osteoarthritis Treatment and Mechanisms (31 papers), RNA Interference and Gene Delivery (16 papers), Peroxisome Proliferator-Activated Receptors (12 papers), Advanced biosensing and bioanalysis techniques (12 papers), Virus-based gene therapy research (6 papers), Electrospun Nanofibers in Biomedical Applications (6 papers) and Bone Metabolism and Diseases (6 papers). The work is most often cited by research in Rheumatology (978 citations), Biomaterials (459 citations) and Pharmaceutical Science (203 citations). Mohamed Benderdour has collaborated with scholars based in Canada, China and Brazil. Frequent co-authors include Julio Fernandes, Patrick Lavigne, Hassan Fahmi, Qin Shi, Éric Beaumont, Johanne Martel‐Pelletier, Jean‐Pierre Pelletier, Karin A. Corsi, Françoise M. Winnik and Pierre Ranger. Their work appears in journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.